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gd T cells uniquely contribute to host immune de-
fense, but how this is accomplished remains unclear.
Here, we analyzed the nonclassical major histocom-
patibility complex class I T10 and T22-specific gd
T cells in mice and found that encountering antigen
in the thymus was neither required nor inhibitory for
their development. But when triggered through the
T cell receptor, ligand-naive lymphoid-gd T cells pro-
duced IL-17, whereas ligand-experienced cellsmade
IFN-g. Immediately after immunization, a large frac-
tion of IL-17+ gd T cells were found in the draining
lymph nodes days before the appearance of anti-
gen-specific IL-17+ ab T cells. Thus, thymic selection
determines the effector fate of gd T cells rather than
constrains their antigen specificities. The swift IL-17
response mounted by antigen-naive gd T cells sug-
gests a critical role for these cells at the onset of an
acute inflammatory response to novel antigens.
INTRODUCTION
gd T cells, ab T cells, and B cells are the only types of cells that
use V(D)J rearrangement to generate diverse receptors to recog-
nize antigens. In adult animals, ab T cells are the predominant
T cell population and perform most of the well-defined functions
attributed to T lymphocytes. Nevertheless, like ab T cells and B
cells, gd T cells are evolutionarily conserved and found in all
jawed vertebrates, suggesting a unique role for these lympho-
cytes in host immune competence.
Although the precise functions of gd T cells remain unclear, it
has been shown that patients with bacterial, parasitic, and viral
infections often have increased numbers of gd T cells in the
peripheral blood (from <5% in healthy individuals to >45% in
patients) (De Paoli et al., 1990; Ho et al., 1990; Jason et al.,90 Immunity 29, 90–100, July 18, 2008 ª2008 Elsevier Inc.2000). It was also reported that gd T cells are overrepresented
among infiltrating T cells in the early but not in the late lesions
of multiple sclerosis patients (up to 20%–30% of the total num-
ber of T cells) (Wucherpfennig et al., 1992). In experimental sys-
tems in which ab T cell- and/or gd T cell-deficient mice are
infected with pathogens, the absence of both T lymphocyte pop-
ulations generally results in a more severe infection. Although gd
T cell-deficient mice usually appear more immune competent
than ab T cell-deficient mice, they do have immune defects
and usually fare worse in neutrophil-dominated inflammatory re-
sponses (King et al., 1999; Koohsari et al., 2007; Moore et al.,
2000; Toth et al., 2004). However, it is unclear why and how gd
T cells are preferentially suited for this task.
gd T cells, like ab T cells, develop in the thymus before entering
the periphery. In the case of ab T cells, thymic development
entails ligand-driven positive and negative selection, which de-
termine what ab T cells can recognize (Huseby et al., 2005;
Van Laethem et al., 2007) and whether these T cells will develop
into CD4+ helper or CD8+ cytolytic T cells. Thus, understanding
gd T cell selection in the thymus may also provide valuable clues
to their likely targets and function.
Previousanalysis of the roleof thymic selection in theestablish-
mentof a functionalgdTcell repertoirehas focusedon thestudies
of KN6 andG8 gd T cell receptor (TCR) transgenicmice. KN6 and
G8 are two independently derived gd T cell clones that recognize
the closely related b2-microglobulin-associated nonclassical
MHC class I molecules, T10 and T22 (Ito et al., 1990; Schild
et al., 1994;Weintraubet al., 1994). Inbothexperimental systems,
transgenic mice were crossed to C57BL/6 (B6) mice, which ex-
press both T10 and T22; BALB/c mice, which only express T10;
or to b2-microglobulin-deficient mice (B2m/), which do not
have cell-surface T10 or T22 expression. When the TCR trans-
genes were expressed in the B6 or B2m/ background, there
were fewer or no transgenic Tcells in the thymusand/or periphery
than when the transgenes were expressed in the BALB/c back-
ground. These transgenic T cells also showed a reduced ability
to secrete cytokines and to proliferate when stimulated in vitro
(Bonneville et al., 1990; Dent et al., 1990; Pereira et al., 1992;
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cluded that gd T cells, similar to ab T cells, undergo ligand-driven
positiveandnegativeselection in the thymus.However, analyzing
the same line of G8 transgenic mice, Schweighoffer and Fowlkes
found thatG8Tcellswereable tomature inB2m/mice, thereby
contradicting the conclusion that positive selection is required
(Schweighoffer and Fowlkes, 1996).
In addition to the KN6 and G8 transgenic systems, the role
of ligand recognition in the development of murine skin-den-
dritic epidermal T cells (DETCs) has also been analyzed. These
gd T cells express the same TCR and are the first to appear
during fetal thymic development (Havran and Allison, 1988).
Although the ligand of these cells has yet to be identified,
DETCs are reactive to keratinocytes in a TCR-dependent man-
ner (Havran et al., 1991). Here, all experimental results suggest
that encountering thymic ligand is necessary for DETCs to mi-
grate to the skin and to acquire their ability to react to kerati-
nocytes (Lewis et al., 2006; Mallick-Wood et al., 1998; Xiong
et al., 2004).
Previously, we found that a sizable population (0.1%–1%) of
gd T cells in normal unimmunized mice recognizes T10 and/or
T22 (Crowley et al., 2000). Surprisingly, a comparable frequency
of T10-and/or-T22-specific gd T cells was also found in B2m/
mice (Crowley, 1998). Moreover, in analyzing the antigen-recog-
nition determinant of T10-and/or-T22-specific gd TCRs, we
found that this specificity is predominantly encoded by amino
acid residues on Vd and Dd gene elements that are brought to-
gether by rearrangement and that 0.85% of the nonselected
TCRd sequences (from CD33-deficient murine thymocytes and
from out-of-frame VDJ recombination events) contain the T10
and/or T22 recognition motif (Shin et al., 2005). This is within
the observed range of T10-and/or-T22-specific gd T cells in nor-
mal mice. Therefore, this repertoire seems to be determined pre-
dominantly by gene rearrangement instead of ligand-dependent
selection. Because we have developed a T22 tetrameric staining
reagent (Crowley et al., 2000) that allows us to follow and analyze
this population of antigen-specific gd T cells in normal nontrans-
genic mice, we decided to re-evaluate the role of ligand recogni-
tion in gd T cell thymic selection and function.
RESULTS
Host T10 and T22 Expression Does Little to Affect
the Presence of T10- and/or T22-Specific gd T Cells
To determine the role of ligand recognition in the development of
a functional gd T cell repertoire, we first used a fluorescently
labeled T22 tetramer to analyze the frequency of T10- and/or
T22-specific gd T cells in C57BL/6, BALB/c, and B2m/ mice.
We found that regardless of the genetic background of the
mice, T10- and/or T22-specific gd T cells were within a similar
range (0.1%–1% of the total gd T cell population) in the
thymuses, spleens, and the interepithelial lymphocyte (IEL) com-
partments (Figure 1A and data not shown) and showed a spec-
trum of affinity to T22 as evaluated by tetramer-staining intensity
(Figure 1B). They expressed TCRs that were diverse in V gene
usage and CDR3 junctional sequences but with the same
(W-SEGYEL) recognition motif in the TCRd CDR3 (data not
shown) as previously described for T10- and/or T22-specific
gd T cells from B10.BR mice (Shin et al., 2005). These resultsindicated that endogenous ligand expression did little to influ-
ence the number, TCR usage, and the recognition motif of
T10- and/or T22-specific gd T cells.
A similar frequency of T10- and/or T22-specific cells was
observed in the thymuses and spleens of mice lacking both
b2m and class II MHC molecules, whether or not they were
treated with cyclosporin A (to inhibit ab T cell-positive selection)
(data not shown). In addition, normal numbers of gd thymocytes
were found in calcineurin-deficient animals (E. Gallo and
G. Crabtree, personal communication). Therefore, the develop-
ment of the T10- and/or T22-specific gd repertoire was neither
inhibited by nor dependent on the expression of T10 or T22, of
class II MHC, or of any other b2m-associated molecules, nor
did it require signaling pathways utilized for ab T cell positive se-
lection. Thus, the development of T10- and/or T22-specific gd
T cells does not require either positive or negative selection, as
described for the development of ab T cells.
Ligand Expression Is Not Required
for gd Thymocyte Development
Thematuration ofgd thymocytes is associatedwith the activation
of the mitogen-activated protein (MAP) kinase (Raf-MEK-ERK)
pathway, which is downstream of TCR signaling (Haks et al.,
2005; Hayes et al., 2005). We found that ERK1 and/or ERK2
(extracellular-signal-regulated kinases 1 and/or 2) were similarly
phosphorylated (pERK1 and/or pERK2) in T10- and/or T22-
specific gd thymocytes from different ligand expressing environ-
ments. In fact, the intracellular pERK1 and/or pERK2 expression
levels in gd thymocytes, regardless of their antigen specificities,
were higher than those from CD4+CD8+ and CD4+CD8 ab thy-
mocytes (Figure 2A and Figure S1 available online). Likewise,
T10- and/or T22-specific gd thymocytes from different genetic
backgrounds also expressed similar amounts of CD5 (Figure 2B),
a stable indicator of signaling strength (Azzam et al., 1998; Tara-
khovsky et al., 1995).
Although it was reported that in the absence of ligand, KN6
TCR transgenic gd T cells (KN6+ RAG2/B2m/) adopt an ab
T cell fate as defined by CD4 and CD8 expression and lowered
gd TCR surface expression (Haks et al., 2005), we found that
tetramer-positive gd T cells inB2m/mice remainedCD4CD8
(Figure 2C) and showed no TCR downregulation (Figure 1C).
These differences may be due to the tendency of endogenous
prerearranged TCR genes to skew T lymphocyte development
(Serwold et al., 2007). In this regard, although a >20-fold in-
crease in CD4+8+ KN6+ T cells was reported in the thymuses
of KN6+ B2m/RAG2/ mice, there was also a 2-fold increase
in the number of CD4CD8 transgenic T cells (Haks et al.,
2005). Therefore, the expansion of the double-positive cells
might not have been at the expense of the gd lineage cells in
that setting.
Upregulation of sphingosine-1-phosphate receptor 1 (S1P1)
is necessary for mature thymocytes to exit the thymus (Matlou-
bian et al., 2004), and we found no observable difference in the
high S1P1 surface expression between tetramer-positive and
tetramer-negative thymocytes from B6 and B2m/ mice
(Figure 2D). Taken together, these results indicate that endoge-
nous thymic ligand expression does very little to constrain gd
thymocyte development and thymic exit. These aspects repre-
sent an important departure from what has been known for abImmunity 29, 90–100, July 18, 2008 ª2008 Elsevier Inc. 91
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gd T Cell Thymic Selection Function, IL-17, IFN-gFigure 1. Frequency and Surface Phenotypes of T10- and/or T22-Specific gd T Cells from Mice with and without T10 and T22 Expression
(A–C) Frequency (A), tetramer staining intensity (B), and TCR surface expression (C) on T10- and/or T22-specific gd thymocytes (left column) and splenocytes
(right column) from C57BL/6 (B6) (T10+T22+) (blue), C57BL/6 B2m/ (T10T22) (red), and BALB/c (T10+T22) (black) mice. Each symbol or histogram repre-
sents the result of one mouse.
(D) Representative FACS analysis of tetramer-positive (red) and tetramer-negative (blue) gd thymocytes and splenocytes for the expression of CD122 (IL-2/IL-15R b
chain) from B6, BALB/c and B2m/ mice.
(E) gd thymocytes, (F) gd splenocytes, and (G) lymph node gd T cells from B6 and B2m/mice were analyzed for the expression of surface markers commonly
associated with antigen recognition by T cells.
gd T cells were first enriched with the pan-gd antibody GL-3, followed by staining with PE-labeled T22 tetramer, antibodies to cell-surface markers, and Cy5PE
labeled anti-CD19, anti-TCRb, Armenian Hamster isotype IgG2k, streptavidin and propidium iodide (PI) as described in Experimental Procedures. Cy5PE and PI
positive cells were excluded from analysis. Representative histogram plots are shown (nR 3).T cell development and what has been thought previously about
gd T cell selection.
TCR Dimerization Provides a Possible Ligand-
Independent Mechanism for Signaling through the TCR
In ab thymocyte development, autonomous signaling mediated
by dimerization of the pre-Ta has been suggested for pre-T
cell activation (Yamasaki et al., 2006). Interestingly, the crystal
structure of the G8 gd TCR with its T22 ligand showed a dimer-92 Immunity 29, 90–100, July 18, 2008 ª2008 Elsevier Inc.ized complex between the TCR Vd domains (Adams et al.,
2005). We therefore tested whether gd TCRs could dimerize to
induce signaling without crosslinking by ligand. The extracellular
domain of the human erythropoietin receptor (EPOR) was re-
placed with the TCRd chain extracellular domain and expressed
together with the extracellular domain of the TCRg chain in BaF3
cells (Figure S2). EPOR signaling mediated through dimerization
of the extracellular domain allows these cells to grow in the ab-
sence of IL-3 (Yoshimura et al., 1990). We found that all of the
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Does Not affect Signaling, Lineage Commit-
ment, or S1P1 Expression of T10- and/or
T22-specific gd thymocytes
Representative FACS analysis of direct ex vivo gd
thymocytes from B6 and B2m/ mice (n = 3).
(A) Intracellular expression of phosphorylated
ERK1 and/or ERK2 in tetramer-positive (red), total
gd thymocytes (blue), and CD4+8+ thymocytes
(shaded).
(B) CD5 surface expression on tetramer-positive
(red) and tetramer-negative (blue) gd thymocytes,
isotype control on GL-3+ gd thymocytes (shaded).
(C) CD4 and CD8 surface expression on tetramer-
positive GL-3+ gd thymocytes (left column) or total
thymocytes (right column).
(D) Sphingosine-1 Phosphate receptor-1 (S1P1)
surface expression on CD4+CD8+ (black), mature
CD4+CD62Lhi ab T cells that have gone through
positive and negative selection and that are ready
for thymic exit (purple), GL-3+ gd thymocytes (red)
(left column), or tetramer-positive (red) and nega-
tive (blue) GL-3+ gd thymocytes (right column).
S1P1 expression was identified with a polyclonal
rabbit antiserum to S1P1 and detected with
FITC-labeled goat anti-rabbit F(ab’)2 secondary.Vg, Vd-EPOR fusion protein pairs, except for Vg5, Vd1-EPOR,
were able to promote the growth of BaF3 cells after IL-3 with-
drawal (Figure 3 and Figure S2). The Vd1, Vg5 TCR we tested
here is from the DETCs. Various reports indicate that these cells
require antigen-driven positive selection for development (Lewis
et al., 2006; Mallick-Wood et al., 1998; Xiong et al., 2004). Thus,
our results offer a possible ligand-independent mechanism for
signaling through the gd TCR (with the exception of the DETC
TCR). TCR dimerization might be sufficient to drive the develop-
ment of gd thymocytes, which had high pERK1 and/or pERK2
levels (Figure S1). In this context, Prinz et al. suggested that
surface expression of the gd TCR on thymocytes was the only
‘‘check point’’ in their development that involved a phase of pro-
liferation with magnitude similar to that induced by the pre-Ta
(Prinz et al., 2006). TCR dimerization might also enhance anti-
gen-specific activation of peripheral gd T cells, which are known
to signal more efficiently than ab T cells (Hayes et al., 2003),
despite lacking CD4 or CD8 coreceptor expression and having
low amounts of pERK1 and/or pERK2, similar to those of naive
ab T cells (Figure S1).
A Large Fraction of Lymphoid gd T Cells Exhibit
an Antigen-Naive Phenotype
Although T10- and/or T22-specific thymocytes in B6, BALB/c,
and B2m/ mice were similar in number and had comparable
tetramer-staining intensities, their phenotypic marker expres-
sion suggested that the majority of them from B6 and BALB/c
mice have encountered antigen and those from B2m/ mice
did not. In particular, T10- and/or T22-specific cells from B6
and BALB/c mice expressed lower amounts of TCR(Figure 1C) and heat-stable antigen (HSA, or J11D) but higher
amounts of the IL-2 and IL-15 receptor common b chain
(CD122) than those from B2m/ mice (Figures 1D and 1E).
Figure 3. TCRd-d Interactions as Assayed by the Induction of BaF3
Cell-Autonomous Growth
The relative growth of TCR-EPOR expressing BaF3 cells to parental BaF3 cells
day 4 after IL-3 withdraw. Ratios are defined as follows: (number of chimeric
EPOR transfectants at day 4 after IL-3 removal/number of transfectants at
day 0)/(number of parental BaF3 cells at day 4 after IL-3 removal/number of pa-
rental BaF3 cells at day 4). The survival curves of the TCR expressing BaF3
cells are shown in Figure S2. pTa-EPOR as previously reported induces
BaF3 cell growth (Yamasaki et al., 2006) and serves as a positive control.
The Vd10, Vg4 G8 TCR was assayed two different ways: Vd10-EPOR, Vg4
and Vg4-EPOR, Vd10. Consistent with the crystal structure of G8 (Adams
et al., 2005), the Vd chain mediates dimerization, and Vd10-EPOR, Vg4 signals
better than Vg4-EPOR, Vd10.Immunity 29, 90–100, July 18, 2008 ª2008 Elsevier Inc. 93
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hances T10- and/or T22-Specific gd T Cell
Turnover but Does Not Fix this Specificity
in the Repertoire
The percentage of BrdU+ cells among tetramer-
positive and negative gd splenocytes from B6,
B2m/, and BALB/c mice were analyzed by intra-
cellular BrdU staining as described in Experimen-
tal Procedures after mice were fed with 0.8 mg/ml
BrdU in their drinking water for 7 days (upper
panels) or 24 days (middle panels) or chased
with normal drinking water for 28 days after the
24 day labeling phase (lower panels). Each dot
represents the analysis of one mouse. Data were
analyzed by a paired, two-tailed student t test.ab thymocytes that encounter ligand express lower levels of
HSA, and an HSAlo profile has also been reported for G8 gd
TCR transgenic thymocytes that develop in the presence of
ligand (Schweighoffer and Fowlkes, 1996; Wells et al., 1991).
Similarly, the upregulation of CD122 has been used as an indi-
cator of self-ligand recognition in ab thymocytes (Hanke et al.,
1994) and during murine skin gd dendritic epidermal cells devel-
opment (Xiong et al., 2004).
Consistent with the idea that exposure to ligand is not neces-
sary for gd T cells to exit from the thymus, T10- and/or T22-spe-
cific gd splenocytes from B2m/ mice exhibited the phenotype
of T cells that have not encountered antigen. Specifically, the
majority of these cells were CD44lo and int and CD122lo and int,
whereas those from B6 mice were CD44hi and CD122hi, and
a greater fraction of these cells were DX5+, NK1.1+, and CD5lo
(Figure 1F). In addition, there were consistently lower numbers
of gd splenocytes with very high tetramer staining in B6 mice
than in B2m/ mice (Figure 1B), suggesting that cells possess-
ing TCRswith very high affinity to T10 and T22 have been deleted
in B6 mice. This observation could explain why G8 transgenic
T cells are not found in the spleens of B6 mice (Dent et al.,
1990) because the G8 TCR has the highest affinity to T10 and
T22 among all the T10- and/or T22-specific receptor pairs we
have analyzed (Shin et al., 2005) (and data not shown).
Notably, the surface-marker expression pattern of tetramer-
negative gd thymocytes and splenocytes (i.e., >99% of the total
gd T cell population) in all strains of mice wasmore similar to that
of T10- and/or T22-specific gd T cells from B2m/mice than to
those from B6 and BALB/c mice (Figures 1D–1F), suggesting
that a large fraction of gd T cells might not have encountered
ligand during their development or in the periphery.
Antigen-Naive gd T Cells Can Turn over In Vivo
To assess the functional properties of T10- and/or T22-specific
gd T cells that were developed in the presence or absence of
T10 and/or T22, we first evaluated their turnover rates in vivo
by measuring the amount of 50-Bromo-2-deoxyuridine (BrdU) in-
corporation in tetramer-positive and tetramer-negative gd sple-94 Immunity 29, 90–100, July 18, 2008 ª2008 Elsevier Inc.nocytes from different strains of mice. As shown in Figure 4,
T10- and/or T22-specific gd T cells from B6 and BALB/c mice in-
corporated significantly more BrdU after 7 days of labeling than
the vast majority of gd T cells. Because T10- and/or T22-specific
gd T cells that developed in B6 and BALB/c mice generally ex-
pressed higher levels of CD122 and CD44 than the rest of gd
T cells, this observation was consistent with the reports that pe-
ripheral CD44hi gd T cells have a higher turnover rate than their
CD44lo and int counterparts (Tough and Sprent, 1998), and IL-15
enhances homeostatic proliferation of gd T cells in lymphopenic
animals (Baccala et al., 2005; French et al., 2005). However, the
difference in the turnover rates was no longer apparent after a 28
day chase preceded by 24 day labeling. Thus, encountering an-
tigen increased the turnover of T10- and/or T22-specific gd
T cells but did not ‘‘fix’’ this specificity in the repertoire. Indeed,
we found no significant differences in the frequency of tetramer-
positive cells from any strain betweenmice aged 2, 7, 12, 14, and
20 weeks (data not shown).
Importantly, tetramer-positive and tetramer-negative gd
T cells from B2m/ mice had similar levels of BrdU incorpora-
tion across all experimental conditions. In addition, the turnover
rate of themajority of the splenic gd T cells fromB6mice are sim-
ilar to that of T10- and/or T22-specific gd T cells that developed
in B2m/ mice (B6 background), supporting the supposition
that a significant number of peripheral gd T cells have yet to
encounter antigen.
Antigen Recognition during Development Defines
gd T Cell Effector Function
To test whether encountering ligand during development affects
the ability of gd T cells tomake cytokines, we analyzed YETI mice
(B6 background), which express an IFN-g- yellow fluorescence
protein (YFP) bicistronic reporter (Stetson et al., 2003). This al-
lowed us to evaluate IFN-g expression with FACS analysis for
YFP because gd T cells are known to make IFN-g (Ferrick
et al., 1995). We found that T10- and/or T22-specific gd spleno-
cytes in YETI mice were mostly YFP+. In fact, most of the
CD122hi YETI splenocytes were also YFP positive (Figure 5A).
Immunity
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(A) gd thymocytes (upper row) and splenocytes
(lower row) from YETI (yellow enhanced transcript
for IFN-g) mice (H-2b, T10+T22+) were analyzed
for YFP (IFN-g) expression in tetramer-positive
(red) and tetramer-negative (blue) cells (left col-
umn) or in CD122hi (red) and CD122lo (blue) cells,
shown in the right column (n = 3); total gd thymo-
cytes or splenocytes from YFP-negative littermate
controls were also analyzed (shaded). FACS anal-
ysis was performed as described in Figure 1.
IFN-g and IL-17 production by CD122hi and
CD122lo gd splenocytes (B) and by CD122hi and
CD122lo gd thymocytes and gd lymph node cells
(C) was analyzed. gd T cells were FACS-sorted
into CD122hi and CD122lo populations according
to the indicated gate in (A) and stimulated with
plate-bound anti-TCRd (GL-4) for 40 hr. Superna-
tants were assayed for the production of IFN-g
and IL-17 by ELISA. In (B), each symbol represents
the result of one mouse, and a representative
graph is shown in (C) (nR 3).Furthermore, CD122hi gd splenocytes from B6 mice stimulated
with plate-bound TCRd crosslinking antibody GL-4 secreted
high amounts of IFN-g (Figure 5B). These results indicate that de-
veloping in the presence of antigen does not render gd T cells
functionally inactive or ‘‘anergic.’’
Conversely, the majority of the CD122lo gd splenocytes from
YETI mice did not express YFP (Figure 5A), and CD122lo B6 gd
splenocytes made very little or no IFN-g upon stimulation
(Figure 5B). Because CD122lo marked cells that had yet to
encounter antigen, we asked whether or not these cells were ca-
pable of making cytokines. Previously, we found IFN-g and IL-17
to be the major cytokines induced in gd T cells after activation
(data not shown) and therefore included IL-17 in the assay. Sur-
prisingly, GL-4-stimulated CD122lo but not CD122hi gd spleno-
cytes secreted large amounts of IL-17 (Figure 5B).
As in the spleen, CD122hi gd thymocytes made IFN-g and
CD122lo thymocytes made IL-17 after GL-4 stimulation
(Figure 5C). Consistent with this observation, in YETI mice,
most of the CD122lo gd thymocytes were YFP negative, and
20% of T10- and/or T22-specific as well as CD122hi thymo-
cytes were YFP+ (Figure 5A). Similar to gd thymocytes and sple-
nocytes, CD122lo but not CD122hi lymph node gd T cells
responded to TCR crosslinking by preferentially making IL-17
(Figure 5C).
Whereas CD122lo gd T cells in the lymphoid organs made
IL-17, this was not the case for gd IELs. These cells were uni-
formly CD122lo regardless of antigen specificity and the host’s
genetic background but were cytolytic in directly ex vivo-redi-
rected lysis assays (Lefrancois and Goodman, 1989) and consti-
tutively expressed high levels of Eomes, Granzyme A and B
(Fahrer et al., 2001; Shires et al., 2001) (data not shown). This
may not be surprising because gd IELs are not only very different
from lymphoidgdTcells in geneexpressionbut also in their devel-
opmental and maturation requirements (Hayes and Love, 2007).
Taken together, these results indicate that lymphoid gd T cells
have at least two different effector types—those that make IL-17,
designated as Tgd-17s and those that make IFN-g, designated
as Tgd-IFN-gs. These two distinct functional subsets of gd T cellsacquire their ability to respond in the thymus, and their pattern of
responses is profoundly influenced by encountering ligand.
Importantly, regardless of their effector functions, gd T cells
responded to TCR triggering readily. This is in stark contrast to
the activation requirements of ab T cells, which require an initial
antigen-specific priming event by professional antigen-present-
ing cells before developing into effectors cells with the capability
to secrete cytokines days later.
IL-17-Producing gd T Cells Appear Early
after Peptide-CFA Immunization
IL-17 regulates the expansion and recruitment of neutrophils and
monocytes to initiate the inflammatory response (Ley et al.,
2006; Stark et al., 2005). In acute inflammation, a swift IL-17 re-
sponse must be elicited without prior antigen exposure. There-
fore, gd T cells may be uniquely suited to produce IL-17 at the
onset of the inflammatory response. To test this directly, we
immunized B6 mice with myelin oligodendrocyte glycoprotein
(MOG) peptide (35–55) in CFA, as a surrogate for the induction
of acute inflammation and to prime antigen-specific ab T cells.
T cells were isolated from the draining lymph nodes and stimu-
lated with anti-CD3 for 24 hr in vitro before intracellular IL-17
staining. As shown in Figure 6, a large fraction of lymph node
gd T cells from B6 mice produced IL-17 before and immediately
after immunization. This is well before the MOG-specific as well
as the CD4+ ab T cell IL-17 response that was not observed until
day 3 or 4. Prior to day 3, gd T cells constitute the largest fraction
(R50%) of IL-17-producing T cells (data not shown).
In B6 mice, T10- and/or T22-specific gd thymocytes showed
a range of CD122 expression (Figure 1D). Whereas most of the
T10- and/or T22-specific gd T cells in the spleen of B6 mice
were CD122hi (Figure 1D), those in the lymph nodes were
CD122lo (Figure 1G). After CFA immunization, CD122lo T10-
and/or T22-specific lymph node gd T cells from B6 mice, as
well as from B2m/mice, made IL-17 when stimulated through
their TCR in this assay (Figure 6E). These results demonstrate
that encountering ligand during development is not required for
gd T cells to respond by producing IL-17.Immunity 29, 90–100, July 18, 2008 ª2008 Elsevier Inc. 95
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(A) Representative intracellular IL-17 staining of gd T cells (GL-3+CD33+) and CD4+ ab T cells (CD4+CD33+GL-3-CD8-); the number represents the percentage of
total T cells that stained positive for intracellular IL-17 as depicted in the indicated gates. Lymph node cells were isolated and stimulated with (+) or without ()
plate-bound anti-CD33 for 24 hr and afterward stained with antibodies against CD4, CD8a, CD33, TCRd, F4/80, CD11b, Gr-1, and CD19 and stained for intra-
cellular IL-17 as described in Experimental Procedures. F4/80-, CD11b-, Gr-1-, and CD19-positive cells were excluded from analysis.
(B) Percentage of IL-17+ cells among total gd T cells (-) or CD4+ ab T cells (B) from the draining lymph nodes at the indicated days after CFA and MOG35-55
immunization and stimulated as in (A). Each symbol represents the result of one mouse.
(C) Representative dose response curves of the MOG33-55-specific IL-17 response at days 0 (A), 3 (,), and 4 (B) after immunization. Lymph node cells were
isolated from individual mice, incubated with various concentrations of MOG33-55 peptide for 48 hr, and assayed for IL-17 in the supernatant. Error bars represent
the standard deviation of the IL-17 response as measured in triplicate wells.
(D) Progression of EAE disease in TCRCd/ (Tcrd-C/) and B6mice after immunization withMOG33-55 and CFA andwith pertussis toxin. The daily mean clinical
score of each group is plotted (see Experimental Procedures); the error bars represent the standard error of the mean (SEM) (n = 4).
(E) IL-17 response of T10- and/or T22-specific gd T cells from B2m/ or B6 mice 4 days after MOG35-55 and CFA immunization, draining lymph node cells from
12B2m/, or B6mice were pooled and stimulated as in (A). gd T cells were enriched, stained with T22 tetramer and assayed for intracellular IL-17 or stained with
Rat IgG1k isotype control. Dot plots display gated GL-3+ H57 CD11b F4/80 Gr1 CD19 gd T cells and the percent of total events within the indicated gates
are displayed.In vertebrates, antigen-specific ab T cell responses are initi-
ated by the inflammatory response. The influx of neutrophils
sets in motion the recruitment of other leukocytes to the site of
inflammation, which in turn affects the local cytokine milieu96 Immunity 29, 90–100, July 18, 2008 ª2008 Elsevier Inc.and subsequent antigen-specific B and T cell responses. In
this context, we have confirmed an earlier report by Weiner
and colleagues (Spahn et al., 1999) that experimental autoim-
mune encephalomyelitis (EAE) can be induced readily by
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onset and much-reduced severity in gd T cell-deficient mice
(Tcrd-C/) on the same genetic background (Figure 6D). This
disease model has been used extensively in the evaluation of
the development of Th17 ab T cells (Bettelli et al., 2007).
DISCUSSION
Inflammation is an essential host response to infection and in-
jury. Although much of the inflammatory response involves the
innate immune system, evolutionarily the requirement of a T
cell cytokine, IL-17, to initiate this process by inducing neutrophil
maturation and their recruitment from the bone marrow (Stark
et al., 2005) coincides with the appearance of the adaptive im-
mune system. Yet, it has been unclear how the early stages of
the IL-17 response could be elicited from classic antigen-spe-
cific ab T cells. Th17 cells can take 4 to 7 days to develop and
require antigen-specific priming, costimulation provided by pro-
fessional antigen-presenting cells, and a particular cytokine
environment (Weaver et al., 2006).
The results presented here, together with our previous studies,
suggest that gd T cells are uniquely suited for the initial IL-17 re-
sponse, which often needs to be elicited without prior antigen
exposure. We and others have demonstrated that gd TCRs can
recognize antigens directly with no requirement for antigen pro-
cessing and presentation (Schild et al., 1994; Weintraub et al.,
1994; Sciammas and Bluestone, 1998). Furthermore, we also
observe that once the antigen specificity is generated, it is only
marginally modified by thymic selection. As a result, gd TCR li-
gands could include pathogen-derived molecules, as well as in-
fection- or injury-induced self-antigens, whichmay ormay not be
expressed in the thymus. Thus, pathogens and damaged tissues
can be recognized directly by gd T cells to initiate immune re-
sponses. In fact, it appears that a large fraction of peripheral
gd T cells have not encountered ligands either in the thymus or
in the periphery. Furthermore, an antigen-naive gd T cell reper-
toire seems to be actively maintained in peripheral lymphoid
organs by turning over rapidly and by not prolonging the lifespan
of gd T cells that have encountered antigen.
Although ligand expression does little to constrain antigen
specificities of the gd T cell repertoire, it does play a role in
endowing lymphoid gd T cells with different functional programs.
We found very clear evidence for two distinct functional subsets
of lymphoid gd T cells (Tgd-17s and Tgd-IFN-gs), which can be
correlated with their antigen experience (or the lack of it).
We also found that the majority of lymph node gd T cells are
Tgd-17s, whereas a large population of splenic gd T cells is
Tgd-IFN-gs. Although the mechanism leading to this biased dis-
tribution is unclear, it appears that ab T cells also show similar
differential ‘‘sorting,’’ in which memory ab T cells (that have en-
countered antigens previously) are preferentially found in the
spleen rather than in the lymph nodes (Forster et al., 1999).
This is particularly intriguing because lymph nodes serve pre-
dominantly as the initial collection point of foreign antigens and
sites for propagating inflammation. Lastly and most importantly,
we found that regardless of ligand experience, gd T cells were
able to make cytokines immediately upon TCR engagement.
Taken together, our characterization of Tgd-17s shows that
they are ideally suited to provide IL-17 in the very earliest stagesof an inflammatory response, before antigen-specific ab T cells
are able to. This may explain reports showing that patients often
have increased numbers of gd T cells early in infection and that
gd T cell-deficient mice usually fare worse in neutrophil-
dominated inflammatory responses to heat-, ozone-, or chlorine-
induced injuries and in bacterial infections (Nocardia asteroids,
Klebsiella pneumonia) (King et al., 1999; Koohsari et al., 2007;
Moore et al., 2000; Toth et al., 2004). In these cases, fewer infil-
trating neutrophils, an increased bacterial load, early dissemina-
tion, and higher mortality rates are noted. Recent experiments
have also reported gd T cells to be major producers of IL-17 in
murine infectious diseasemodels such asMycobacterium tuber-
culosis (Lockhart et al., 2006), Mycobacterium bovis (Umemura
et al., 2007), Escherichia coli (Shibata et al., 2007), and pulmo-
nary aspergillosis in chronic granulomatous disease (CGD)
(Romani et al., 2008) and in a mouse model of autoimmunity
(Roark et al., 2007).
The regulation of early neutrophil infiltration is important to re-
set the cytokine milieu, and engulfment of dying neutrophils is
a major contributor to the reprogramming of macrophage cyto-
kine-secretion patterns, which affects the development of the
adaptive immune response. If gd T cells play a major role in reg-
ulating neutrophil influx at the beginning of this process, then
they are likely to affect the subsequent development of ab T
cell and B cell responses. Indeed, deviated ab T cell and B cell
responses in gd T cell-deficient mice have been reported (Spahn
et al., 1999; Zuany-Amorim et al., 1998), including the lack of EAE
induction, as first shown by Weiner and colleagues and repro-
duced by us in this work.
In summary, gd T cells are different from ab T cells in both their
antigen-recognition and -activation requirements, and also their
TCR repertoire and effector-fate development. These aspects
allow gd T cells to function in the first line of defense to patho-
gens or cellular trauma. Although gd T cells form an integral
part of the adaptive immune response, their principle role is
not to substitute for ab T cells or B cells but rather to influence
the functional responses of these cells as the inflammatory re-
sponse develops. Thus, the rapid onset of IL-17 induction in an-
tigen-naive gd T cells may hold the key to understanding how gd
T cells contribute to host immune competence and why they
have been maintained throughout vertebrate evolution.
EXPERIMENTAL PROCEDURES
Mice
Six- to eight-week-old age- and sex-matched C57BL/6, BALB/c, B2m/
(C57BL/6), Tcrd-C/ (B6.129P2-Tcrdtm1Mom/J), and b2m MHC II null mice
(B6.129-H2-Ab1tm1Gru B2mtm1Jae N17) were purchased from either Jackson
or Taconic laboratories and housed in the Stanford Animal Facility according
to guidelines set by Stanford. YETI (yellow enhanced transcript for IFN-g)
mice (Stetson et al., 2003) (C57BL/6, H-2b N6) were housed at UCSF accord-
ing to guidelines set by UCSF.
Antibodies
All antibodies were purchased from eBioscience or BD PharMingen unless
otherwise stated.
FACS Analysis of gd T Cells
To enrich gd T cells, we first incubated total thymocytes and splenocytes
(108 cells/ml) with normal hamster serum, normal mouse serum (Jackson Im-
munoResearch), and 5 mg/ml anti-CD16/32 FcBlock, subsequently incubatedImmunity 29, 90–100, July 18, 2008 ª2008 Elsevier Inc. 97
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them with anti-fluorescein isothiocyanate (FITC) or allophycocyanin (APC)
MicroBeads (Miltenyi).
For staining GL-3-enriched gd T cells with T22 tetramer, cells were further
blocked with 4 mg/mL CD8aCT (CALTAG) to prevent CD8-tetramer binding
and then stained with 5-7 mg/ml phycoerythrin (PE)-labeled T22 tetramer,
together with anti-CD19 Cy5PE (MB 19-1), anti-TCRb Cy5PE (H57), anti-KLH
Armenian Hamster IgG2k Cy5PE (GL-3 isotype), and streptavidin Cy5PE
(BD PharMingen), for 1.5 hr on ice. After washing, cells were suspended in
FACS buffer (2% FCS PBS) with 1 mg/ml propidium iodide (PI). Six-color
FACS was performed on Vantage or LSR, and data were collected with Cell
Quest software. Cells positive for PI and Cy5PE were excluded from analysis.
FACS data were compensated and analyzed with FlowJo software (Treestar).
For staining tetramer-positive gd T cells for the expression of cell-surface
markers, enriched and tetramer-stained gd T cells were concurrently stained
with one of the following antibodies labeled with FITC (unless otherwise
stated): anti-CD122 (TM-b1), anti-HSA (M1/69), anti-CD127 (A7R34), anti-
CD5 (53-7.3), anti-CD25 Alexa488 (3C7), anti-NK1.1 APC (NKR-P1C), anti-
CD49b (DX5), anti-CD44 (IM7), anti-CD4 APC-Cy7 (15-8-A2), anti-CD8
(CD8aCT, CALTAG), Rat IgG2ak FITC (53-7.3 isotype), or anti-S1P1 polyclonal
(UCSF) detected with FITC-labeled goat anti-rabbit F(ab’)2 secondary (Jack-
son ImmunoResearch). Tetramer-positive, tetramer-negative, and GL-3-posi-
tive cells were analyzed for maker expression and plotted by a histogram. For-
analyzing YETI mice, TCRd (GL-3) and CD33 Cy7APC (145-2C11) double-
positive cells were analyzed for tetramer or anti-CD122 PE staining and YFP
(IFN-g) expression.
Intracellular Staining of pERK1 and/or pERK2 or BrdU
in Tetramer-Positive gd T Cells
For detection of intracellular levels of pERK1 and/or pERK2 or BrdU in T22 tet-
ramer-positive cells, cell suspensions from the thymus or spleen were blocked
with serums, FcBlock, and CD8aCT as described above; stained with 15–
20 mg/ml PE-labeled tetramer; and enriched with anti-PE MicroBeads (Milte-
nyi). After enrichment, 50%–70% of the TCRd+CD33+ cells were tetramer
positive. Tetramer-enriched cells were stained with relevant antibodies,
fixed with Cytofix/Cytoperm solution on ice, and permeabilized with Cyto-
perm/Wash buffer (BD PharMingen). For the detection of phosphorylated
ERK1 and/or ERK2, cells were stained with rabbit 197G2 (Cell Signaling) for
45 min at room temperature. After washing, cells were stained with FITC-
labeled anti-rabbit F(ab)2 secondary (Jackson ImmunoResearch) for 30 min
at room temp and then washed with Cytoperm/Wash and FACS buffers. For
the detection of BrdU incorporation, samples were further permeabilized with
Cytofix/Cytoperm Plus buffer (BD PharMingen) then treated with 30 mg DNase
(Sigma-Aldrich) for 60 min at 37C to expose BrdU epitopes. After washing,
cells were stained with anti-BrdU APC (3D4) for 45 min at room temperature
and then washed.
In Vitro Stimulation and the Detection of IFN-g and IL-17
CD122hi and CD122lo gd thymocytes, splenocytes, and lymph node cells were
FACS sorted with a Vantage cell sorter, and 105 cells/well were plated on a
96-well plate (Costar) coated with 10 mg/ml anti-TCRd (GL-4). Cells were cul-
tured in RPMI 1640+GlutaMAX-1 supplemented with 10% fetal-calf serum
(Hyclone), 0.1 mM nonessential amino acids (Cellgro), 1 mM sodium pyruvate
(Irvine Scientific), 100 U/ml penicillin, 100 mg/ml streptomycin (GIBCO), and
3.5 ml/L 2-mercaptoethanol (Sigma). Supernatant was analyzed for IFN-g
and IL-17 by ELISA (eBioscience) 40 hr later.
Construction, Expression of TCR-EPOR Hybrid Genes
in BaF3 Cells, and the Proliferation Assay
The TCRd extracellular region (defined by a multiple sequence alignment pro-
vided by the international ImMunoGeneTics information system database) was
linked to the transmembrane (TM) and intracellular sequence of the human
EPOR, and the TCRg extracellular region (defined as above) was linked to
and terminated at the end of the EPOR TM region by PCR. PCR products
were TA cloned (Invitrogen), sequenced, inserted into a pMX IRES-GFP vector
(Yamasaki et al., 2006), and transfected into ecotrophic Phoenix cells with
FuGene 6 Transfection reagent (Roche) according to the manufacturer’s sug-
gestions. Viral supernatant was obtained and Vd-EPOR, Vg chain pairs were98 Immunity 29, 90–100, July 18, 2008 ª2008 Elsevier Inc.used for infection of BaF3 cells grown in 1 ng/ml mouse IL-3 (R&D systems).
Transfectants were FACS-sorted for high (upper 10%) of GFP expression.
For the proliferation assay, sorted transfectants were washed three times
and mixed with equal numbers of washed parental BaF3 (GFP-negative) cells,
such that 105 cells/400 ml of each cell type were plated in a 48-well plate. Var-
ious days after IL-3 removal, PI was added directly to the medium and cells
were resuspended and enumerated by FACS. The absolute number of GFP+
or GFP (parental BaF3) cells various days after IL-3 removal divided by the
absolute number obtained on day 0 was plotted for Figure S2. For Figure 3B,
the fold growth over parental BaF3 cells on day 4 was plotted and calculated
as follows: (number of chimeric EPOR transfectants at day 4 after IL-3 re-
moval/number of transfectants at day 0)/(number of parental BaF3 cells at
day 4 after IL-3 removal/number of parental BaF3 cells at day 4).
MOG35-55 and CFA Immunization, Intracellular IL-17 Detection,
and the MOG35-55-Specific IL-17 Lymph node Response
Mice were immunized subcutaneously with 100 mg of HPLC-purifiedMOG35-55
peptide (MEVGWYRSPFSRVVHLYRNGK) and 200 mg of heat-killed mycobac-
terium (DIFCO) emulsified in 1 part mineral oil and 1 part H20 (Complete
Freund’s Adjuvant). Axillary, brachial, and inguinal lymph nodes were har-
vested at various days after immunization. Total cell suspensions were plated
at 53 106 cells per well in 48-well plates (Falcon) precoated with 10 mg/ml anti-
CD33 (145-2C11, no azide, low endotoxin) or Armenian Hamster IgG1k (BD).
Five hours prior termination of the assay, Monensin and Brefeldin A (eBio-
science) were added to the culture medium. After incubating 24 hr at 37C,
cells were harvested, blocked with serums and FcBlock as described above,
and stained with antibodies against CD4 (GK1.5), CD8 (CD8aCT), CD33 (145-
2C11), TCRd (GL-3), F4/80 (BM8), CD11b (M1/70), Gr-1 (RB6-8C5), and CD19
(MB19-1). For tetramer analysis, cells were enriched with GL-3 and anti-FITC
microbeads before staining with APC-labeled T22 tetramer and dump anti-
bodies as described above. Cells were then washed with FACS buffer, fixed,
and permeabilized with Cytofix and Cytoperm/Wash buffers. Cells were
stained with 2 mg/ml PE-labeled anti-IL-17 (TC11-18H10, BD PharMingen) or
IgG1,k isotype (R3-34, BD PharMingen) for 30 min on ice in Cytoperm/Wash
buffer. Cells were washed as described before. CD11b-, Gr-1-, F4/80-, and
CD19-positive cells were excluded from analysis. Isotype staining was used
to define cytokine-positive cells.
For detection of the MOG33-55-specific IL-17 lymph node response, lymph
node cells from individual mice were isolated various days before and after
peptide-CFA immunization. A total of 106 cells were plated in a 96-well plate
and incubated with various concentrations of MOG33-55 peptide in RPMI cul-
ture medium. Supernatant was harvested 48 hr later and monitored for IL-17
with anti-IL-17 beads (Bender MedSystems) according to the manufacturer’s
protocol.
EAE was induced in C57BL/6 and Tcrd-C/ (B6) mice by subcutaneous im-
munization withMOGpeptide as described above. On the day of immunization
and 2 days later, mice were injected intravenously with 50 ng ofBordetella per-
tussis toxin in PBS. Mice were examined each day for clinical signs of EAE and
scored as follows: 0, no paralysis; 1, loss of tail tone; 2, hindlimb weakness;
3, hindlimb paralysis; 4, hindlimb and forelimb paralysis; and 5, moribund or
dead.
SUPPLEMENTAL DATA
Supplemental Data include two figures and can be foundwith this article online
at http://www.immunity.com/cgi/content/full/29/1/90/DC1/.
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